HealthDay News -- Women with metastatic breast cancer who developed an immune response to an investigational vaccine lived twice as long as those who didn’t have an immune response, new research shows.
HealthDay News -- Women with metastatic breast cancer who developed an immune response to an investigational vaccine lived twice as long as those who didn’t have an immune response, new research shows.